| Cirrhosis+portal hypertension (major) |
Any severe liver disease |
Major criteria |
| Active cancer (1 year) (major) |
Cancer <3 years |
Major criteria |
| Spontaneous bleeding requiring admission and/or transfusion <6 months or at any time if recurrent (major) |
Transfusion <4 weeks (and haemoglobin >110 g/L at baseline) |
Major criteria |
| Non-deferrable surgery on dual antiplatelet therapy post PCI (major) |
Planned surgery during the first month after PCI |
Major criteria |
| Moderate or severe ischaemic stroke <6 months (major) or any prior ischaemic stroke (minor) |
Prior stroke <1 year |
Minor criteria |
| Spontaneous bleeding <12 months (minor) |
Hospital admission for bleeding <12 months |
Minor criteria |
| Chronic use of NSAIDS or steroids (>4 tablets/week) |
Planned NSAIDS/steroids for >30 days after PCI |
Minor criteria |
| NSAIDS: non-steroidal anti-inflammatory drugs; PCI: percutaneous coronary intervention |
